Skip to main content
Erschienen in: Clinical Rheumatology 11/2009

01.11.2009 | Original Article

Subclinical atherosclerosis and endothelial dysfunction in young South-Asian patients with systemic lupus erythematosus

verfasst von: Parasar Ghosh, Amresh Kumar, Sudeep Kumar, Amita Aggarwal, Nakul Sinha, Ramnath Misra

Erschienen in: Clinical Rheumatology | Ausgabe 11/2009

Einloggen, um Zugang zu erhalten

Abstract

Patients with systemic lupus erythematosus (SLE), especially Asian Indians, are at increased risk of developing premature atherosclerosis. To find out the prevalence and predictors of carotid intima-medial thickness (IMT) and brachial artery flow-mediated dilatation (FMD). Endothelial dysfunction was assessed by FMD in brachial artery and IMT was measured in common carotid artery in SLE patients and healthy controls. Sixty SLE patients (mean age 31 ± 9 years) and 38 healthy controls (mean age 34 ± 6 years) were included. The IMT was higher in SLE patients as compared to controls (0.49 ± 0.08 mm vs. 0.39 ± 0.05 mm, p < 0.0001). SLE and damage were independent predictors of abnormal IMT. FMD was impaired in SLE patients compared to controls (9.97% vs. 18.97%, p < 0.00001). None of the classical cardiovascular risk factors were predictors of FMD or abnormal IMT. Indian patients with SLE have higher prevalence of subclinical atherosclerosis and endothelial dysfunction. Presence of damage was associated with abnormal IMT in SLE patients.
Literatur
1.
Zurück zum Zitat Urowitz MB, Bookman AA, Koehler BE, Gordon DA, Smythe HA, Ogryzlo MA (1976) The bimodal mortality pattern of systemic lupus erythematosus. Am J Med 60:221–225PubMedCrossRef Urowitz MB, Bookman AA, Koehler BE, Gordon DA, Smythe HA, Ogryzlo MA (1976) The bimodal mortality pattern of systemic lupus erythematosus. Am J Med 60:221–225PubMedCrossRef
2.
Zurück zum Zitat Bjornadal L, Yin L, Granath F, Klareskog L, Ekbom A (2004) Cardiovascular disease a hazard despite improved prognosis in patients with systemic lupus erythematosus: results from a Swedish population based study 1964–95. J Rheumatol 31:713–719PubMed Bjornadal L, Yin L, Granath F, Klareskog L, Ekbom A (2004) Cardiovascular disease a hazard despite improved prognosis in patients with systemic lupus erythematosus: results from a Swedish population based study 1964–95. J Rheumatol 31:713–719PubMed
3.
Zurück zum Zitat Esdaile JM, Abrahamowicz M, Grodzicky T et al (2001) Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus. Arthritis Rheum 44:2331–2337PubMedCrossRef Esdaile JM, Abrahamowicz M, Grodzicky T et al (2001) Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus. Arthritis Rheum 44:2331–2337PubMedCrossRef
4.
Zurück zum Zitat Manzi S, Meilahn EN, Rairie JE et al (1997) Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham study. Am J Epidemiol 145:408–415PubMed Manzi S, Meilahn EN, Rairie JE et al (1997) Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham study. Am J Epidemiol 145:408–415PubMed
5.
Zurück zum Zitat Vita JA, Keaney JF Jr, Larson MG et al (2004) Brachial artery vasodilator function and systemic inflammation in the Framingham offspring study. Circulation 110:3604–3609PubMedCrossRef Vita JA, Keaney JF Jr, Larson MG et al (2004) Brachial artery vasodilator function and systemic inflammation in the Framingham offspring study. Circulation 110:3604–3609PubMedCrossRef
6.
Zurück zum Zitat Vlachoyiannopoulos PG, Kanellopoulos PG, Ioannidis JP, Tektonidou MG, Mastorakou I, Moutsopoulos HM (2003) Atherosclerosis in premenopausal women with antiphospholipid syndrome and systemic lupus erythematosus: a controlled study. Rheumatology (Oxford) 42:645–651CrossRef Vlachoyiannopoulos PG, Kanellopoulos PG, Ioannidis JP, Tektonidou MG, Mastorakou I, Moutsopoulos HM (2003) Atherosclerosis in premenopausal women with antiphospholipid syndrome and systemic lupus erythematosus: a controlled study. Rheumatology (Oxford) 42:645–651CrossRef
7.
Zurück zum Zitat de Leeuw K, Sanders JS, Stegeman C, Smit A, Kallenberg CG, Bijl M (2005) Accelerated atherosclerosis in patients with Wegener's granulomatosis. Ann Rheum Dis 64:753–759PubMedCrossRef de Leeuw K, Sanders JS, Stegeman C, Smit A, Kallenberg CG, Bijl M (2005) Accelerated atherosclerosis in patients with Wegener's granulomatosis. Ann Rheum Dis 64:753–759PubMedCrossRef
8.
Zurück zum Zitat Petri M, Lakatta C, Magder L, Goldman D (1994) Effect of prednisone and hydroxychloroquine on coronary artery disease risk factors in systemic lupus erythematosus: a longitudinal data analysis. Am J Med 96:254–259PubMedCrossRef Petri M, Lakatta C, Magder L, Goldman D (1994) Effect of prednisone and hydroxychloroquine on coronary artery disease risk factors in systemic lupus erythematosus: a longitudinal data analysis. Am J Med 96:254–259PubMedCrossRef
9.
Zurück zum Zitat Roman MJ, Shanker BA, Davis A et al (2003) Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus. N Engl J Med 349:2399–2406PubMedCrossRef Roman MJ, Shanker BA, Davis A et al (2003) Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus. N Engl J Med 349:2399–2406PubMedCrossRef
10.
Zurück zum Zitat Greenland P, Abrams J, Aurigemma GP et al (2000) Prevention Conference V: beyond secondary prevention: identifying the high-risk patient for primary prevention: noninvasive tests of atherosclerotic burden: Writing Group III. Circulation 101:E16–E22PubMed Greenland P, Abrams J, Aurigemma GP et al (2000) Prevention Conference V: beyond secondary prevention: identifying the high-risk patient for primary prevention: noninvasive tests of atherosclerotic burden: Writing Group III. Circulation 101:E16–E22PubMed
11.
Zurück zum Zitat Bots ML, Hoes AW, Koudstaal PJ, Hofman A, Grobbee DE (1997) Common carotid intima–media thickness and risk of stroke and myocardial infarction: the Rotterdam study. Circulation 96:1432–1437PubMed Bots ML, Hoes AW, Koudstaal PJ, Hofman A, Grobbee DE (1997) Common carotid intima–media thickness and risk of stroke and myocardial infarction: the Rotterdam study. Circulation 96:1432–1437PubMed
12.
Zurück zum Zitat Chambless LE, Heiss G, Folsom AR et al (1997) Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: the Atherosclerosis Risk in Communities (ARIC) study, 1987–1993. Am J Epidemiol 146:483–494PubMed Chambless LE, Heiss G, Folsom AR et al (1997) Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: the Atherosclerosis Risk in Communities (ARIC) study, 1987–1993. Am J Epidemiol 146:483–494PubMed
13.
Zurück zum Zitat Hodis HN, Mack WJ, LaBree L et al (1998) The role of carotid arterial intima–media thickness in predicting clinical coronary events. Ann Intern Med 128:262–269PubMed Hodis HN, Mack WJ, LaBree L et al (1998) The role of carotid arterial intima–media thickness in predicting clinical coronary events. Ann Intern Med 128:262–269PubMed
14.
Zurück zum Zitat O'Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Wolfson SK Jr (1999) Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. N Engl J Med 340:14–22PubMedCrossRef O'Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Wolfson SK Jr (1999) Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. N Engl J Med 340:14–22PubMedCrossRef
15.
Zurück zum Zitat Manzi S, Selzer F, Sutton-Tyrrell K et al (1999) Prevalence and risk factors of carotid plaque in women with systemic lupus erythematosus. Arthritis Rheum 42:51–60PubMedCrossRef Manzi S, Selzer F, Sutton-Tyrrell K et al (1999) Prevalence and risk factors of carotid plaque in women with systemic lupus erythematosus. Arthritis Rheum 42:51–60PubMedCrossRef
16.
Zurück zum Zitat Selzer F, Sutton-Tyrrell K, Fitzgerald SG et al (2004) Comparison of risk factors for vascular disease in the carotid artery and aorta in women with systemic lupus erythematosus. Arthritis Rheum 50:151–159PubMedCrossRef Selzer F, Sutton-Tyrrell K, Fitzgerald SG et al (2004) Comparison of risk factors for vascular disease in the carotid artery and aorta in women with systemic lupus erythematosus. Arthritis Rheum 50:151–159PubMedCrossRef
17.
Zurück zum Zitat Piper MK, Raza K, Nuttall SL et al (2007) Impaired endothelial function in systemic lupus erythematosus. Lupus 16:84–88PubMedCrossRef Piper MK, Raza K, Nuttall SL et al (2007) Impaired endothelial function in systemic lupus erythematosus. Lupus 16:84–88PubMedCrossRef
18.
Zurück zum Zitat Lima DS, Sato EI, Lima VC, Miranda F Jr, Hatta FH (2002) Brachial endothelial function is impaired in patients with systemic lupus erythematosus. J Rheumatol 29:292–297PubMed Lima DS, Sato EI, Lima VC, Miranda F Jr, Hatta FH (2002) Brachial endothelial function is impaired in patients with systemic lupus erythematosus. J Rheumatol 29:292–297PubMed
19.
Zurück zum Zitat El-Magadmi M, Bodill H, Ahmad Y et al (2004) Systemic lupus erythematosus: an independent risk factor for endothelial dysfunction in women. Circulation 110:399–404PubMedCrossRef El-Magadmi M, Bodill H, Ahmad Y et al (2004) Systemic lupus erythematosus: an independent risk factor for endothelial dysfunction in women. Circulation 110:399–404PubMedCrossRef
20.
Zurück zum Zitat Mohan V, Deepa R (2004) Risk factors for coronary artery disease in Indians. J Assoc Physicians India 52:95–97PubMed Mohan V, Deepa R (2004) Risk factors for coronary artery disease in Indians. J Assoc Physicians India 52:95–97PubMed
21.
Zurück zum Zitat Enas EA, Yusuf S, Mehta JL (1992) Prevalence of coronary artery disease in Asian Indians. Am J Cardiol 70:945–949PubMedCrossRef Enas EA, Yusuf S, Mehta JL (1992) Prevalence of coronary artery disease in Asian Indians. Am J Cardiol 70:945–949PubMedCrossRef
22.
Zurück zum Zitat McKeigue PM, Miller GJ, Marmot MG (1989) Coronary heart disease in South Asians overseas: a review. J Clin Epidemiol 42:597–609PubMedCrossRef McKeigue PM, Miller GJ, Marmot MG (1989) Coronary heart disease in South Asians overseas: a review. J Clin Epidemiol 42:597–609PubMedCrossRef
23.
Zurück zum Zitat Bhatt SP, Handa R, Gulati GS et al (2006) Atherosclerosis in Asian Indians with systemic lupus erythematosus. Scand J Rheumatol 35:128–132PubMedCrossRef Bhatt SP, Handa R, Gulati GS et al (2006) Atherosclerosis in Asian Indians with systemic lupus erythematosus. Scand J Rheumatol 35:128–132PubMedCrossRef
24.
Zurück zum Zitat Grover S, Sinha RP, Singh U, Tewari S, Aggarwal A, Misra R (2006) Subclinical atherosclerosis in rheumatoid arthritis in India. J Rheumatol 33:244–247PubMed Grover S, Sinha RP, Singh U, Tewari S, Aggarwal A, Misra R (2006) Subclinical atherosclerosis in rheumatoid arthritis in India. J Rheumatol 33:244–247PubMed
25.
Zurück zum Zitat Bahl VK, Sharma G (2001) Coping with syncope: tilt towards pacing. Indian Heart J 53:415–422PubMed Bahl VK, Sharma G (2001) Coping with syncope: tilt towards pacing. Indian Heart J 53:415–422PubMed
26.
Zurück zum Zitat Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40:1725PubMedCrossRef Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40:1725PubMedCrossRef
27.
Zurück zum Zitat Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH (1992) Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 35:630–640PubMedCrossRef Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH (1992) Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 35:630–640PubMedCrossRef
28.
Zurück zum Zitat Gladman D, Ginzler E, Goldsmith C et al (1996) The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index for Systemic Lupus Erythematosus. Arthritis Rheum 39:363–369PubMedCrossRef Gladman D, Ginzler E, Goldsmith C et al (1996) The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index for Systemic Lupus Erythematosus. Arthritis Rheum 39:363–369PubMedCrossRef
29.
Zurück zum Zitat Sidhu PS, Desai SR (1997) A simple and reproducible method for assessing intimal–medial thickness of the common carotid artery. Br J Radiol 70:85–89PubMed Sidhu PS, Desai SR (1997) A simple and reproducible method for assessing intimal–medial thickness of the common carotid artery. Br J Radiol 70:85–89PubMed
30.
Zurück zum Zitat Corretti MC, Anderson TJ, Benjamin EJ et al (2002) Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol 39:257–265PubMedCrossRef Corretti MC, Anderson TJ, Benjamin EJ et al (2002) Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol 39:257–265PubMedCrossRef
31.
Zurück zum Zitat Svenungsson E, Jensen-Urstad K, Heimburger M et al (2001) Risk factors for cardiovascular disease in systemic lupus erythematosus. Circulation 104:1887–1893PubMedCrossRef Svenungsson E, Jensen-Urstad K, Heimburger M et al (2001) Risk factors for cardiovascular disease in systemic lupus erythematosus. Circulation 104:1887–1893PubMedCrossRef
32.
Zurück zum Zitat Reichlin M, Fesmire J, Quintero-Del-Rio AI, Wolfson-Reichlin M (2002) Autoantibodies to lipoprotein lipase and dyslipidemia in systemic lupus erythematosus. Arthritis Rheum 46:2957–2963PubMedCrossRef Reichlin M, Fesmire J, Quintero-Del-Rio AI, Wolfson-Reichlin M (2002) Autoantibodies to lipoprotein lipase and dyslipidemia in systemic lupus erythematosus. Arthritis Rheum 46:2957–2963PubMedCrossRef
33.
Zurück zum Zitat Doria A, Shoenfeld Y, Wu R et al (2003) Risk factors for subclinical atherosclerosis in a prospective cohort of patients with systemic lupus erythematosus. Ann Rheum Dis 62:1071–1077PubMedCrossRef Doria A, Shoenfeld Y, Wu R et al (2003) Risk factors for subclinical atherosclerosis in a prospective cohort of patients with systemic lupus erythematosus. Ann Rheum Dis 62:1071–1077PubMedCrossRef
34.
Zurück zum Zitat Souza AW, Hatta FS, Miranda F Jr, Sato EI (2005) Atherosclerotic plaque in carotid arteries in systemic lupus erythematosus: frequency and associated risk factors. Sao Paulo Med J 123:137–142PubMedCrossRef Souza AW, Hatta FS, Miranda F Jr, Sato EI (2005) Atherosclerotic plaque in carotid arteries in systemic lupus erythematosus: frequency and associated risk factors. Sao Paulo Med J 123:137–142PubMedCrossRef
35.
Zurück zum Zitat Jimenez S, Garcia-Criado MA, Tassies D et al (2005) Preclinical vascular disease in systemic lupus erythematosus and primary antiphospholipid syndrome. Rheumatology (Oxford) 44:756–761CrossRef Jimenez S, Garcia-Criado MA, Tassies D et al (2005) Preclinical vascular disease in systemic lupus erythematosus and primary antiphospholipid syndrome. Rheumatology (Oxford) 44:756–761CrossRef
36.
Zurück zum Zitat Colombo BM, Murdaca G, Caiti M et al (2007) Intima–media thickness: a marker of accelerated atherosclerosis in women with systemic lupus erythematosus. Ann N Y Acad Sci 1108:121–126PubMedCrossRef Colombo BM, Murdaca G, Caiti M et al (2007) Intima–media thickness: a marker of accelerated atherosclerosis in women with systemic lupus erythematosus. Ann N Y Acad Sci 1108:121–126PubMedCrossRef
37.
Zurück zum Zitat Sato H, Miida T, Wada Y et al (2007) Atherosclerosis is accelerated in patients with long-term well-controlled systemic lupus erythematosus (SLE). Clin Chim Acta 385:35–42PubMedCrossRef Sato H, Miida T, Wada Y et al (2007) Atherosclerosis is accelerated in patients with long-term well-controlled systemic lupus erythematosus (SLE). Clin Chim Acta 385:35–42PubMedCrossRef
38.
Zurück zum Zitat Lopez LR, Salazar-Paramo M, Palafox-Sanchez C, Hurley BL, Matsuura E, Garcia-De La Torre I (2006) Oxidized low-density lipoprotein and beta2-glycoprotein in patients with systemic lupus erythematosus and increased carotid intima–media thickness: implications in autoimmune-mediated atherosclerosis. Lupus 15:80–86PubMedCrossRef Lopez LR, Salazar-Paramo M, Palafox-Sanchez C, Hurley BL, Matsuura E, Garcia-De La Torre I (2006) Oxidized low-density lipoprotein and beta2-glycoprotein in patients with systemic lupus erythematosus and increased carotid intima–media thickness: implications in autoimmune-mediated atherosclerosis. Lupus 15:80–86PubMedCrossRef
39.
Zurück zum Zitat Wolak T, Todosoui E, Szendro G et al (2004) Duplex study of the carotid and femoral arteries of patients with systemic lupus erythematosus: a controlled study. J Rheumatol 31:909–914PubMed Wolak T, Todosoui E, Szendro G et al (2004) Duplex study of the carotid and femoral arteries of patients with systemic lupus erythematosus: a controlled study. J Rheumatol 31:909–914PubMed
40.
Zurück zum Zitat Anderson TJ, Elstein E, Haber H, Charbonneau F (2000) Comparative study of ACE-inhibition, angiotensin II antagonism, and calcium channel blockade on flow-mediated vasodilation in patients with coronary disease (BANFF study). J Am Coll Cardiol 35:60–66PubMedCrossRef Anderson TJ, Elstein E, Haber H, Charbonneau F (2000) Comparative study of ACE-inhibition, angiotensin II antagonism, and calcium channel blockade on flow-mediated vasodilation in patients with coronary disease (BANFF study). J Am Coll Cardiol 35:60–66PubMedCrossRef
41.
Zurück zum Zitat Ghiadoni L, Magagna A, Versari D et al (2003) Different effect of antihypertensive drugs on conduit artery endothelial function. Hypertension 41:1281–1286PubMedCrossRef Ghiadoni L, Magagna A, Versari D et al (2003) Different effect of antihypertensive drugs on conduit artery endothelial function. Hypertension 41:1281–1286PubMedCrossRef
42.
Zurück zum Zitat Mancini GB, Henry GC, Macaya C et al (1996) Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease. The TREND (trial on reversing endothelial dysfunction) study. Circulation 94:258–265PubMed Mancini GB, Henry GC, Macaya C et al (1996) Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease. The TREND (trial on reversing endothelial dysfunction) study. Circulation 94:258–265PubMed
43.
Zurück zum Zitat Sudhir K, MacGregor JS, Gupta M et al (1993) Effect of selective angiotensin II receptor antagonism and angiotensin converting enzyme inhibition on the coronary vasculature in vivo. Intravascular two-dimensional and Doppler ultrasound studies. Circulation 87:931–938PubMed Sudhir K, MacGregor JS, Gupta M et al (1993) Effect of selective angiotensin II receptor antagonism and angiotensin converting enzyme inhibition on the coronary vasculature in vivo. Intravascular two-dimensional and Doppler ultrasound studies. Circulation 87:931–938PubMed
44.
Zurück zum Zitat Kawamoto R, Ohtsuka N, Kusunoki T, Yorimitsu N (2008) An association between the estimated glomerular filtration rate and carotid atherosclerosis. Intern Med 47:391–398PubMedCrossRef Kawamoto R, Ohtsuka N, Kusunoki T, Yorimitsu N (2008) An association between the estimated glomerular filtration rate and carotid atherosclerosis. Intern Med 47:391–398PubMedCrossRef
45.
Zurück zum Zitat Thambyrajah J, Landray MJ, McGlynn FJ, Jones HJ, Wheeler DC, Townend JN (2000) Abnormalities of endothelial function in patients with predialysis renal failure. Heart 83:205–209PubMedCrossRef Thambyrajah J, Landray MJ, McGlynn FJ, Jones HJ, Wheeler DC, Townend JN (2000) Abnormalities of endothelial function in patients with predialysis renal failure. Heart 83:205–209PubMedCrossRef
46.
Zurück zum Zitat Hashimoto M, Eto M, Akishita M et al (1999) Correlation between flow-mediated vasodilatation of the brachial artery and intima–media thickness in the carotid artery in men. Arterioscler Thromb Vasc Biol 19:2795–2800PubMed Hashimoto M, Eto M, Akishita M et al (1999) Correlation between flow-mediated vasodilatation of the brachial artery and intima–media thickness in the carotid artery in men. Arterioscler Thromb Vasc Biol 19:2795–2800PubMed
47.
Zurück zum Zitat Urowitz MB, Ibanez D, Gladman DD (2007) Atherosclerotic vascular events in a single large lupus cohort: prevalence and risk factors. J Rheumatol 34:70–75PubMed Urowitz MB, Ibanez D, Gladman DD (2007) Atherosclerotic vascular events in a single large lupus cohort: prevalence and risk factors. J Rheumatol 34:70–75PubMed
48.
Zurück zum Zitat Petri M, Perez-Gutthann S, Spence D, Hochberg MC (1992) Risk factors for coronary artery disease in patients with systemic lupus erythematosus. Am J Med 93:513–519PubMedCrossRef Petri M, Perez-Gutthann S, Spence D, Hochberg MC (1992) Risk factors for coronary artery disease in patients with systemic lupus erythematosus. Am J Med 93:513–519PubMedCrossRef
49.
Zurück zum Zitat Shah MA, Shah AM, Krishnan E (2009) Poor outcomes after acute myocardial infarction in systemic lupus erythematosus. J Rheumatol 36:570–575PubMedCrossRef Shah MA, Shah AM, Krishnan E (2009) Poor outcomes after acute myocardial infarction in systemic lupus erythematosus. J Rheumatol 36:570–575PubMedCrossRef
50.
Zurück zum Zitat Urowitz MB, Gladman DD (2008) The SLICC inception cohort for atherosclerosis. Curr Rheumatol Rep 10:281–285PubMedCrossRef Urowitz MB, Gladman DD (2008) The SLICC inception cohort for atherosclerosis. Curr Rheumatol Rep 10:281–285PubMedCrossRef
Metadaten
Titel
Subclinical atherosclerosis and endothelial dysfunction in young South-Asian patients with systemic lupus erythematosus
verfasst von
Parasar Ghosh
Amresh Kumar
Sudeep Kumar
Amita Aggarwal
Nakul Sinha
Ramnath Misra
Publikationsdatum
01.11.2009
Verlag
Springer-Verlag
Erschienen in
Clinical Rheumatology / Ausgabe 11/2009
Print ISSN: 0770-3198
Elektronische ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-009-1228-6

Weitere Artikel der Ausgabe 11/2009

Clinical Rheumatology 11/2009 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.